Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

International Journal of Cardiology

Volumn 92, Issue 2-3, 2003, Pages 285-293

  Nageh, Thuraia ^a   Sherwood, Roy A ^a   Harris, Beverly M ^a   Byrne, Jonathan A ^a   Thomas, Martyn R ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cardiac troponins; Creatine kinase MB; Percutaneous coronary intervention; Prognostic markers

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE MB; TROPONIN I; TROPONIN T;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; CELL DAMAGE; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE MARKER; FEMALE; FOLLOW UP; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RISK; TREATMENT OUTCOME;

EID: 0344666482     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(03)00105-0     Document Type: Article

References (47)

1. Klein L.W., Kiemer B.L., Howard E., et al. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 17:1991;621-626.
2. Ravkilde J., Nissem H., Mickley H., et al. Cardiac Troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J. 127:1994;13-20.
3. Kuglemass A.D., Cohen D.J., Muscucci M., et al. Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 74:1994;784-794.
4. Abdelmeguid A.E., Topol E.J. The myth of the myocardial "infarctlet" during percutaneous coronary revascularisation procedure. Circulation. 94:1996;3369-3375.
5. Abdelmeguid A.E., Topol E.J., Whitlow P.L., et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 94:1996;1528-1536.
6. Tardiff B.E., Califf R.M., Tchang J.E., et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol. 33:1999;88-96.
7. Katus H.A., Remppis A., Neumann F.J., et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
8. Adams J.E., Bodor G.S., Devile-Roman V.G., et al. Cardiac Troponin I: a marker with high specificity for cardiac injury. Circulation. 88:1993;101-106.
9. Wu A.H.B., Feng Y.-J., Moore R., et al. Characterisation of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem. 44:1998;1198-1208.
10. Collinson P.O. Troponin T or Troponin I or CK-MB (or none?). Eur Heart J. 19:(suppl N):1998;N16-N24.
11. Hamm C.W. Progress in the diagnosis of unstable angina and perspectives for treatment. Eur Heart J. 19:(Suppl N):1998;N48-N50.
12. Harris B.M., Nageh T., Marsden J.T., et al. Comparison of cardiac Troponin T and I and CK-MB for the detection of minor myocyte damage during interventional cardiac procedures. Ann Clin Biochem. 27:2000;764-769.
13. Antman E., Bassand J.-P., Werner K., et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 36:2000;959-969.
14. Hartmann F., Kampmann M., Fray N., et al. Biochemical markers in the diagnosis of coronary artery disease. Eur Heart J. 19:(suppl N):1998;N2-N7.
15. Bodor G.S., Survant L., Voss E.M., et al. Cardiac Troponin T composition in normal and regenerating human skeletal muscle. Clin Chem. 43:1996;476-484.
16. Rottbauer W., Greten T., Muller-Bardorff M., et al. Troponin T: a diagnostic marker for myocardial infarction and minor cardiac damage. Eur Heart J. 17:(Suppl F):1997;F3-F8.
17. Amsterdam E.A., Lewis W.R. Identification of low risk patients with chest pain in the emergency department: another look at cardiac troponins. J Am Coll Cardiol. 32:1998;15-16.
18. Newby L.K., Kaplan A.L., Granger B.B., et al. Comparison of cardiac Troponin T versus CK-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol. 85:2000;801-805.
19. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum Troponin T in unstable angina. New Engl J Med. 327:1992;146-151.
20. Li D., Jilal I., Keffer J. Greater frequency of increased cardiac troponin T than increased troponin I in patients with chronic renal failure. Clin Chem. 42:1996;114-115.
21. Apple F.S., Sharkey S.W., Hoeft P., et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients; a 1 year outcome analysis. Am J Kidney Dis. 28:1997;399-403.
22. Collinson P.O., Hadcocks L., Foo A.Y., et al. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem. 35:1998;380-386.
23. McLaurin M.D., Apple F.S., Voss E.M., et al. Cardiac Troponin I, cardiac Troponin T and Creatine Kinase-MB in dialysis patients without ischaemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem. 43:1997;976-982.
24. Musso P., Cox I., Vidano E., et al. Cardiac Troponin elevations in chronic renal failure: prevalence and clinical significance. Clin Biochem. 32:1999;125-130.
25. Baum H., Braun S., Gerhardt W., et al. Multicenter evaluation of a second-generation assay for cardiac troponin T. Clin Chem. 43:1997;1877-1884.
26. Apple F.S., Ricchiuti V., Voss E.M., et al. Expression of cardiac troponin T isoforms in skeletal muscle of renal disease patients will not cause false-positive serum results by the second generation cardiac torponin T assay. Eur Heart J. 19:(suppl N):1998;N30-N33.
27. Paneghini M. Standardisation activities of markers of cardiac damage: the need for a comprehensive approach. Eur Heart J. 19:(suppl N):1998;N8-N11.
28. Apple F.S. Clinical and analytical standardisation issues confronting cardiac troponin I. Clin Chem. 45:1999;18-20.
29. Shyu K.-G., Pei-Lieng K., Jun-Jack C., et al. Cardiac troponin T, creatine kinase and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J. 135:1998;862-867.
30. Ohman E.M., Marquis J.-F., Ricci D.R., et al. A randomised comparison of the effects of gradual prolonged versus standard primary balloon inflation on early and late outcome. Circulation. 89:1994;1118-1125.
31. Johansen O., Brekke M., Stromme J.H., et al. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. Eur Heart J. 1998;19112-19117.
32. Lindahl B., Venge P., Wallentin L. Relation between Troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 93:1996;1651-1657.
33. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac Troponin T levels for risk stratification in acute myocardial ischaemia. New Engl J Med. 335:1996;1333-1341.
34. Luscher M.S., Thygesen K., Ravkilde J., Heickendorff L. Applicability of cardiac Troponin T and I for early risk stratification in unstable coronary artery disease. Circulation. 96:1997;25789-25795.
35. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific Troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Engl J Med. 335:1996;1342-1349.
36. Galvani M., Ottani F., Ferrini D., et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 95:1997;2053-2059.
37. Polanczyk C.A., Lee T.H., Cook F., et al. Cardiac Troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol. 32:1998;8-14.
38. Simoons M.L., van den Brand M., Lincoff M., et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J. 20:1999;1112-1119.
39. Bertinchant J.P., Polge A., Ledermann B., et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol. 84:1999;51-57.
40. Fuchs S., Kovnowski R., Mehran R., et al. Prognostic value of cardiac troponin I levels following catheter based coronary interventions. Am J Cardiol. 85:2000;1077-1082.
41. Tcheng J.E. Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE and EPILOG trials into perspective. Am J Cardiol. 78:1996;35-40.
42. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary intervention. New Engl J Med. 336:1997;1689-1696.
43. Hamm C.W., Heeschen C., Goldman B., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin levels. New Engl J Med. 340:1999;1623-1629.
44. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. New Engl J Med. 338:1998;1488-1497.
45. Lindahl B., Venge P., Wallentin L., et al. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol. 29:1997;43-48.
46. Bonz A.W., Langenfelder B., Strotmann J., et al. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pre-treatment with aspirin and Clopidogrel (TOPSTAR trial). J Am Coll Cardiol. 40:2002;662-668.
47. Buffon A., Biasucci L.M., Liuzzo G., et al. Widespread coronary inflammation in unstable angina. New Engl J Med. 347:2002;5-12.